Company Overview of ProStrakan, Inc.
ProStrakan, Inc. develops and delivers oncology supportive care products. The company offers SANCUSO, a granisetron transdermal system for the prevention of nausea and vomiting in patients receiving moderately and highly emetogenic chemotherapy regimens. Its products are available in the United States, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Portugal, Scotland, Spain, Sweden, the Netherlands, and the United Kingdom. The company was incorporated in 1998 and is based in Bedminster, New Jersey. ProStrakan, Inc. operates as a subsidiary of ProStrakan Group plc.
1430 US State Highway 206
Bedminster, NJ 07921-2652
Founded in 1998
Key Executives for ProStrakan, Inc.
ProStrakan, Inc. Key Developments
Similar Private Companies By Industry
|Bryce Rx Laboratories, Inc.||United States|
|Virologix Corp.||United States|
|Baxter Pharmaceutical Solutions LLC||United States|
|Salix Pharmaceuticals, Inc.||United States|
|Morria Biopharmaceuticals Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ProStrakan, Inc., please visit www.prostrakan-usa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.